Feasibility and Acceptability Trial to Reduce Tobacco and Cannabis Use During Pregnancy and Postpartum (PICTURe)

University of Pittsburgh

Status: Not yet enrolling

Conditions: Cannabis Use; Perinatal; Smoking Cessation; Tobacco Use

Treatments: Behavioral: Perinatal smoking cessation treatment and maintenance sessions

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT07489443

STUDY25110016

1R01DA057946-01A1 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

Using both tobacco and cannabis during pregnancy is more common in minoritized groups and can make quitting smoking in pregnancy and remaining smoke free postpartum difficult. Investigators will test an intervention to address prenatal depressive symptoms to encourage people to quit tobacco and cannabis during pregnancy and stay quit postpartum.

Enrollment: 25 estimated patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Confirmed pregnant
• Under 26 weeks gestation
• Plan to remain pregnant
• English speaking
• Use of combustible tobacco at least once a week during pregnancy, or at least once a week in the 3 months before pregnancy if stopped
• Use of cannabis at any frequency during pregnancy or in the 3 months before pregnancy if stopped

Exclusion criteria

• Current opioid use or active treatment for Opioid Use Disorder
• Unable to provide informed consent in English
• Under 18 years old

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

25 participants in 1 patient group

Feasibility and Acceptability Trial

Experimental group

Treatment:

Behavioral: Perinatal smoking cessation treatment and maintenance sessions